Buscar resultados de ensayos clínicos

Patrocinado por

Diffuse Cutaneous Systemic Sclerosis - 23 Studies Found

Estado Estudiar
Active, not recruiting Nombre del estudio: A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
Condición: Diffuse Cutaneous Systemic Sclerosis
Fecha: 2014-06-03
Intervenciones:
  • Drug: Abatacept Subjects will

Completed Nombre del estudio: Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
Condición: Early Diffuse Cutaneous Systemic Sclerosis
Fecha: 2014-12-22
Intervenciones:
  • Drug: Methotrexate Immunosuppr
Completed Nombre del estudio: Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis
Condición:
  • Scleroderma, Diffuse
  • Diffuse Cutaneous Systemic Sclerosis

    • Fecha: 2015-06-30
    Intervenciones:
    • Drug: IVA337 Capsules of 200mg
Active, not recruiting Nombre del estudio: Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis
Condición: Diffuse Cutaneous Systemic Sclerosis
Fecha: 2015-06-04
Intervenciones:
  • Drug: JBT-101 JBT-101 5 mg q a
Completed Nombre del estudio: Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Condición: Systemic Sclerosis
Fecha: 2012-08-15
Intervenciones: Drug: Belimumab Belimumab (Benlysta®) decreases B-Cell survival and has been FDA approved for the t
Completed Nombre del estudio: Mycophenolate Mofetil in Systemic Sclerosis
Condición: Diffuse Cutaneous Systemic Sclerosis
Fecha: 2007-02-07
Intervenciones: Drug: Mycophenolate Mofetil Mycophenolate 3000 mg each day
Completed Nombre del estudio: AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis
Condición: Systemic Sclerosis
Fecha: 2008-10-07
Intervenciones:
  • Drug: Hyperimmune caprine serum

Not yet recruiting Nombre del estudio: Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Condición: Scleroderma, Systemic
Fecha: 2017-01-31
Intervenciones:
  • Drug: GSK2330811 GSK2330811 wi
Withdrawn Nombre del estudio: A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Condición: Scleroderma
Fecha: 2015-10-26
Intervenciones:
  • Drug: BMS-986020
  • Other: Placebo
Completed Nombre del estudio: Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Condición:
  • Scleroderma, Diffuse
  • Scleroderma, Systemic
  • Scleroderma, Li
    Fecha: 2016-02-08
    Intervenciones:
    • Drug: Oral Ifetroban Subjects

Next >>>